| scholarly article | Q13442814 |
| P50 | author | Katalin A Wilkinson | Q86910301 |
| Robert J. Wilkinson | Q30423489 | ||
| Charlotte Schutz | Q55098478 | ||
| Graeme Meintjes | Q55098484 | ||
| P2093 | author name string | Lori E Dodd | |
| Dominique J Pepper | |||
| Suzaan Marais | |||
| Zahiera Ismail | |||
| P2860 | cites work | Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults | Q28472258 |
| Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings | Q28749315 | ||
| Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis | Q81788096 | ||
| Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy | Q82600740 | ||
| Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients | Q82702521 | ||
| Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting. | Q33916426 | ||
| Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults | Q33982474 | ||
| Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: diagnostic value and relationship to disease severity and outcome | Q33992984 | ||
| Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome | Q34130659 | ||
| Neuroradiological features of the tuberculosis-associated immune reconstitution inflammatory syndrome | Q34251655 | ||
| Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice. | Q34310523 | ||
| Central nervous system disorders after starting antiretroviral therapy in South Africa | Q34799534 | ||
| Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis | Q35121804 | ||
| Integration of antiretroviral therapy with tuberculosis treatment | Q35600960 | ||
| Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome | Q35622163 | ||
| Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy | Q35656939 | ||
| Timing of antiretroviral therapy for HIV-1 infection and tuberculosis | Q35890799 | ||
| Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome | Q36238260 | ||
| Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis | Q36934339 | ||
| Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome | Q37098501 | ||
| Use of corticosteroids in treating infectious diseases | Q37173624 | ||
| Immune reconstitution disease of the central nervous system. | Q37447778 | ||
| Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy | Q37635400 | ||
| Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis | Q37718319 | ||
| The International HIV Dementia Scale: a new rapid screening test for HIV dementia | Q38880627 | ||
| Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy | Q38920844 | ||
| Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. | Q40428500 | ||
| Immune reconstitution syndrome in a patient with AIDS with paradoxically deteriorating brain tuberculoma. | Q40451568 | ||
| Cytokine profiles in HIV seropositive patients with tuberculous meningitis | Q43069819 | ||
| When to start antiretroviral therapy in HIV-associated tuberculosis. | Q43567066 | ||
| Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy | Q45756500 | ||
| Diagnosis of tuberculous meningitis: clinical and laboratory parameters | Q46321459 | ||
| Paradoxical reaction during treatment of tuberculous brain abscess in a patient with AIDS. | Q48250477 | ||
| Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. | Q51869965 | ||
| Mediators of Innate and Adaptive Immune Responses Differentially Affect Immune Restoration Disease Associated withMycobacterium tuberculosisin HIV Patients Beginning Antiretroviral Therapy | Q57254155 | ||
| Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages | Q58042107 | ||
| A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis | Q79667585 | ||
| Immune reconstitution inflammatory syndrome associated with disseminated mycobacterial infection in patients with AIDS | Q80823848 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meningitis | Q48143 |
| tuberculous meningitis | Q3854687 | ||
| P304 | page(s) | 450-460 | |
| P577 | publication date | 2012-10-24 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome | |
| P478 | volume | 56 |
| Q34126700 | A 43 year-old woman with Fever eleven years after kidney transplantation. |
| Q42061660 | A Patient Presenting with Tuberculous Encephalopathy and Human Immunodeficiency Virus Infection |
| Q39508267 | Aberrant Inflammasome Activation Characterizes Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome |
| Q45969852 | Central Nervous System Tuberculosis: Challenges and Advances in Diagnosis and Treatment. |
| Q37442512 | Central nervous system immune reconstitution inflammatory syndrome. |
| Q27002573 | Clinical and Microbiological Features of Salmonella Meningitis in a South African Population, 2003-2013 |
| Q38173299 | Clinical management of tuberculous meningitis: experiences of 42 cases and literature review |
| Q28817395 | Complex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosis |
| Q33920429 | Confusion in the Study of Immune Reconstitution Inflammatory Syndrome. |
| Q57826971 | Corticosteroids as an adjunct to tuberculosis therapy |
| Q35056457 | Cytotoxic mediators in paradoxical HIV-tuberculosis immune reconstitution inflammatory syndrome |
| Q36124569 | Determinants of treatment-related paradoxical reactions during anti-tuberculosis therapy: a case control study. |
| Q41005378 | Diagnostic Performance of Brain MRI in Immune Reconstitution Inflammatory Syndrome |
| Q38113260 | Drug-resistant tuberculous meningitis |
| Q52726617 | Emergence of Polyfunctional Cytotoxic CD4+ T Cells in Mycobacterium avium Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Patients. |
| Q26774211 | Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections |
| Q36970184 | HIV and co-infections |
| Q36815449 | HIV-1 and the immune response to TB. |
| Q36654015 | HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome |
| Q36129630 | HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling |
| Q30252460 | Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines |
| Q50200827 | Human Immunodeficiency Virus in the Brain-Culprit or Facilitator? |
| Q42209595 | Immune reconstitution disorders in patients with HIV infection: from pathogenesis to prevention and treatment. |
| Q38186797 | Immune reconstitution inflammatory syndrome associated with bacterial infections |
| Q35100818 | Immune reconstitution inflammatory syndrome in HIV-infected patients |
| Q33553788 | Inflammasome Activation Underlying Central Nervous System Deterioration in HIV-Associated Tuberculosis |
| Q26749428 | Integrated therapy for HIV and tuberculosis |
| Q36458503 | Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis |
| Q90339086 | Intracranial tuberculous mass lesions treated with thalidomide in an immunocompetent child from a low tuberculosis endemic country: A case report |
| Q97418947 | JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review |
| Q34455442 | Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review |
| Q91616611 | Management of active tuberculosis in adults with HIV |
| Q89668821 | Management of intracranial tuberculous mass lesions: how long should we treat for? |
| Q38107500 | Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons |
| Q39569711 | Matrix Degradation in Human Immunodeficiency Virus Type 1-Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study |
| Q62734088 | Matrix Metalloproteinases in Pulmonary and Central Nervous System Tuberculosis—A Review |
| Q28389802 | Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy |
| Q34282914 | Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome |
| Q47555666 | Neurological Sequelae of Adult Meningitis in Africa: A Systematic Literature Review. |
| Q31155487 | Neurotuberculosis immune reconstitution inflammatory syndrome in the setting of HIV infection: A case report and review of literature |
| Q34488659 | Neutrophil-associated central nervous system inflammation in tuberculous meningitis immune reconstitution inflammatory syndrome |
| Q38414352 | Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review |
| Q38522810 | Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis |
| Q36058313 | Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis |
| Q57290249 | Pre-treatment cerebrospinal fluid bacterial load correlates with inflammatory response and predicts neurological events during tuberculous meningitis treatment |
| Q37250893 | Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial). |
| Q34407741 | Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseas |
| Q64881941 | Reply to Dian et al. |
| Q37626335 | Role of IL-6 in Mycobacterium avium--associated immune reconstitution inflammatory syndrome |
| Q36137088 | Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV |
| Q28074247 | Six months therapy for tuberculous meningitis |
| Q38431923 | Spinal cord involvement in tuberculous meningitis |
| Q36273077 | Standardized Methods for Enhanced Quality and Comparability of Tuberculous Meningitis Studies |
| Q41391847 | TB-IRIS after initiation of antiretroviral therapy is associated with expansion of preexistent Th1 responses against Mycobacterium tuberculosis antigens |
| Q38127598 | The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome |
| Q92169436 | The neurocritical care of tuberculous meningitis |
| Q52680275 | Treatment of Tuberculous Meningitis and Its Complications in Adults. |
| Q39523548 | Treatment-Associated Inflammatory Deterioration in Tuberculous Meningitis: Unpicking the Paradox |
| Q64091806 | Trends of tuberculosis meningitis and associated mortality in Texas, 2010-2017, a large population-based analysis |
| Q40046111 | Tuberculosis Meningitis |
| Q51054145 | Tuberculosis and HIV Coinfection. |
| Q34083196 | Tuberculosis in children. |
| Q38192061 | Tuberculosis-immune reconstitution inflammatory syndrome in HIV: from pathogenesis to prediction |
| Q57827115 | Tuberculous meningitis |
| Q42018926 | Tuberculous meningitis: Diagnostic and therapeutic challenges. |
| Q38360615 | Tuberculous meningitis: advances in diagnosis and treatment. |
| Q38131175 | Tuberculous meningitis: more questions, still too few answers |
Search more.